심혈관 임플란트 시장 보고서 : 제품 유형별, 재질별, 시술종별, 적응증별, 지역별(2025-2033년)

The global cardiovascular implants market size reached USD 27.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 45.0 Billion by 2033, exhibiting a growth rate (CAGR) of 5.32% during 2025-2033. The rising prevalence of cardiovascular diseases, the expanding geriatric population, and significant advancements in the healthcare sector, represent some of the key factors driving the market.

Cardiovascular implants are specialized medical tools used to treat various cardiovascular diseases (CVDs), including heart failure, coronary artery disease, peripheral arterial disease, aortic disease, and myocardial infarction. They are fitted inside the body to support the proper functioning of the heart and blood vessels and to alleviate symptoms associated with abnormal heart rhythms. These devices are made from titanium, pyrolytic carbon, silicone, and plastic mesh and are equipped with an implantable cardioverter-defibrillator (ICD) generator and wires that are insulated with polyurethane (PU) polymer. Cardiovascular implants can detect severe heart rhythms and send signals to maintain normal heart function.

Key Market Segmentation:

Product Type Insights:

• Coronary Stent
• ICD
• Heart Valve
• Implanted Cardiac Pacemaker
• CRT Device
• Peripheral Stent

Material Insights:

• Metals and Alloys
• Polymers
• Biological Materials

Procedure Type Insights:

• Angioplasty
• Open Heart Surgery

Indication Insights:

• Arrhythmias
• Myocardial Ischemia
• Acute Myocardial Infarction
• Congestive Heart Failure
• Others

Regional Insights:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for cardiovascular implants. Some of the factors driving the North America cardiovascular implants market included the rising prevalence of CVDs, innovative product advancements, and the growing geriatric population.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global cardiovascular implants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.

Key Questions Answered in This Report

• 1.How big is the cardiovascular implants market?
• 2.What is the expected growth rate of the global cardiovascular implants market during 2025-2033?
• 3.What are the key factors driving the global cardiovascular implants market?
• 4.What has been the impact of COVID-19 on the global cardiovascular implants market?
• 5.What is the breakup of the global cardiovascular implants market based on the product type?
• 6.What is the breakup of the global cardiovascular implants market based on the indication?
• 7.What are the key regions in the global cardiovascular implants market?
• 8.Who are the key players/companies in the global cardiovascular implants market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cardiovascular Implants Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product Type
• 5.5 Market Breakup by Material
• 5.6 Market Breakup by Procedure Type
• 5.7 Market Breakup by Indication
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Product Type

• 6.1 Coronary Stent
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 ICD
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Heart Valve
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Implanted Cardiac Pacemaker
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 CRT Device
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Peripheral Stent
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Material

• 7.1 Metals and Alloys
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Polymers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Biological Materials
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Procedure Type

• 8.1 Angioplasty
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Open Heart Surgery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Indication

• 9.1 Arrhythmias
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Myocardial Ischemia
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Acute Myocardial Infarction
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Congestive Heart Failure
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Others
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Europe
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 Global Cardiovascular Implants Industry: SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Global Cardiovascular Implants Industry: Value Chain Analysis

13 Global Cardiovascular Implants Industry: Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Global Cardiovascular Implants Industry: Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 BIOTRONIK SE & Co. KG
  • 15.3.2 Abbott Laboratories
  • 15.3.3 AMG International
  • 15.3.4 B. Braun Melsungen AG
  • 15.3.5 Johnson & Johnson Services, Inc.
  • 15.3.6 W. L. Gore & Associates, Inc.
  • 15.3.7 Medtronic Private Limited
  • 15.3.8 Boston Scientific Corporation
  • 15.3.9 Sorin Corporation
  • 15.3.10 Edwards Lifesciences Corporation
  • 15.3.11 Fortimedix Surgical B.V.
  • 15.3.12 Neovasc Inc.
  • 15.3.13 CryoLife Inc.
  • 15.3.14 Proxy Biomedical Ltd.
  • 15.3.15 REVA Medical, LLC.
  • 15.3.16 Shree Pacetronix Ltd.